Dr. Pagel on the Utility of CAR T-Cell Therapy in Relapsed/Refractory DLBCL
John M. Pagel, MD, PhD, discusses the utility of CAR T-cell therapy in patients with relapsed/refractory diffuse large B-cell lymphoma.
